ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 129 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $14,000 | +180.0% | 15,197 | +289.7% | 0.00% | – |
Q4 2021 | $5,000 | 0.0% | 3,900 | +2.6% | 0.00% | – |
Q3 2021 | $5,000 | +25.0% | 3,800 | +8.6% | 0.00% | – |
Q2 2021 | $4,000 | +300.0% | 3,500 | +180.7% | 0.00% | – |
Q4 2018 | $1,000 | -97.0% | 1,247 | -89.2% | 0.00% | -100.0% |
Q3 2018 | $33,000 | +106.2% | 11,494 | +100.0% | 0.00% | +100.0% |
Q2 2018 | $16,000 | -33.3% | 5,747 | -17.3% | 0.00% | -50.0% |
Q1 2018 | $24,000 | +26.3% | 6,947 | -40.9% | 0.00% | +100.0% |
Q4 2017 | $19,000 | -76.8% | 11,747 | -40.2% | 0.00% | -66.7% |
Q3 2017 | $82,000 | +1071.4% | 19,647 | -21.4% | 0.00% | – |
Q2 2017 | $7,000 | -82.1% | 25,000 | -79.4% | 0.00% | -100.0% |
Q1 2017 | $39,000 | -86.2% | 121,100 | -55.8% | 0.00% | -80.0% |
Q4 2016 | $282,000 | +173.8% | 274,116 | +164.3% | 0.01% | +100.0% |
Q3 2016 | $103,000 | +32.1% | 103,730 | +400.4% | 0.01% | +25.0% |
Q2 2016 | $78,000 | -39.1% | 20,731 | -62.7% | 0.00% | -55.6% |
Q1 2016 | $128,000 | -85.9% | 55,557 | -76.8% | 0.01% | -82.0% |
Q4 2015 | $905,000 | – | 239,565 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |